Amylyx Pharmaceuticals, Inc. (AMLX)

15.02 +0.91 (+6.45%) USD  |  NASDAQ  |  Mar 04, 16:00
15.02 0.00 (0.00%) After-Hours: 17:44
More

Amylyx Pharmaceuticals Net Change in Capital Expenditures (% of Quarterly Assets)

Net Change in Capital Expenditures (% of Quarterly Assets) Chart

View Net Change in Capital Expenditures (% of Quarterly Assets) for AMLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years

View Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks

View Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks
Start Trial
Rapt Therapeutics, Inc. Upgrade
Disc Medicine, Inc. Upgrade
Cytokinetics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
MediciNova, Inc. Upgrade